UroGen Pharma reported revenue of $72.46M and net income of -$14.36M for the quarter ended Jun 2026, up 199.2% year over year. This income statement covers 39 quarters of results from Dec 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||||||||
| Revenue | 11.35M | 16.17M | 13.56M | 16.60M | 16.10M | 18.09M | 17.19M | 21.14M | 20.85M | 23.53M | 18.78M | 21.85M | 25.20M | 24.57M | 20.25M | 24.21M | 27.48M | 37.84M | 50.96M | 72.46M | |||||||||||||||||||
| Cost of RevenueCost of Rev | 1.24M | 1.59M | 1.52M | 1.85M | 2.02M | 2.26M | 2.27M | 2.44M | 2.37M | 2.29M | 1.73M | 2.23M | 2.45M | 2.47M | 2.33M | 3.55M | 3.28M | 3.29M | 4.14M | 6.57M | |||||||||||||||||||
| Gross Profit | 10.11M | 14.59M | 12.04M | 14.76M | 14.08M | 15.83M | 14.93M | 18.70M | 18.48M | 21.24M | 17.05M | 19.62M | 22.75M | 22.09M | 17.92M | 20.66M | 24.20M | 34.55M | 46.82M | 65.88M | |||||||||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 11.92M | 13.08M | 12.70M | 12.64M | 13.09M | 14.48M | 12.50M | 11.58M | 10.23M | 11.30M | 15.49M | 15.40M | 11.36M | 14.89M | 19.87M | 18.91M | 14.01M | 14.31M | 15.60M | 17.34M | |||||||||||||||||||
| Selling, General & AdministrativeSG&A | 21.62M | 21.42M | 21.30M | 20.83M | 19.07M | 21.63M | 24.47M | 22.49M | 21.75M | 24.55M | 27.30M | 30.06M | 28.94M | 34.86M | 34.97M | 43.20M | 37.58M | 39.35M | 51.49M | 48.44M | |||||||||||||||||||
| Operating ExpensesOpex | 33.55M | 34.50M | 34.00M | 33.47M | 32.16M | 36.11M | 36.97M | 34.08M | 31.98M | 35.85M | 42.79M | 45.46M | 40.30M | 49.75M | 54.84M | 62.11M | 51.59M | 53.66M | 67.08M | 65.77M | |||||||||||||||||||
| Operating IncomeOp. Inc | -23.44M | -19.91M | -21.96M | -18.71M | -18.09M | -20.28M | -22.05M | -15.38M | -13.50M | -14.61M | -25.74M | -25.84M | -17.55M | -27.66M | -36.91M | -41.45M | -27.39M | -19.11M | -20.26M | 0.11M | |||||||||||||||||||
| EBIT | -23.44M | -19.91M | -21.96M | -18.71M | -18.09M | -20.28M | -22.05M | -15.38M | -13.50M | -14.61M | -25.74M | -25.84M | -17.55M | -27.66M | -36.91M | -41.45M | -27.39M | -19.11M | -20.26M | 0.11M | |||||||||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.06M | 0.02M | -0.04M | 0.13M | 0.48M | 0.41M | 0.63M | 0.41M | 0.91M | 1.54M | 1.61M | 1.71M | 2.60M | 2.75M | 2.11M | 1.30M | 0.98M | 0.90M | 0.61M | 0.60M | |||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | -0.02M | -0.08M | -0.00M | 0.10M | 0.04M | -0.06M | -0.01M | -0.03M | 0.07M | ||||||||||||||||||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||||||||
| EBT | -30.21M | -27.32M | -28.07M | -26.66M | -25.12M | -28.18M | -30.19M | -24.08M | -21.89M | -22.16M | -32.23M | -33.37M | -23.58M | -34.86M | -43.45M | -48.92M | -34.40M | -26.64M | -28.35M | -8.72M | |||||||||||||||||||
| Tax ProvisionsTaxes | -25.47M | 0.33M | 0.03M | 0.71M | -25.91M | 0.02M | 0.05M | -0.01M | -22.68M | 0.05M | 0.04M | 0.09M | -28.71M | 0.39M | 1.01M | -1.05M | -35.64M | -4.77M | 5.63M | ||||||||||||||||||||
| Profit After TaxPAT | -30.25M | -28.48M | -28.44M | -26.69M | -25.93M | -28.82M | -30.21M | -24.14M | -21.88M | -26.02M | -32.34M | -33.40M | -23.67M | -37.51M | -43.88M | -49.95M | -33.35M | -26.37M | -23.59M | -14.36M | |||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -30.21M | -1.85M | -28.39M | -26.69M | -25.83M | -2.27M | -30.21M | -24.14M | -21.88M | 0.52M | -32.29M | -33.40M | -23.67M | -6.15M | -43.84M | -49.94M | -33.35M | 9.00M | -23.57M | -14.35M | |||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -30.21M | -1.85M | -28.39M | -26.69M | -25.83M | -2.27M | -30.21M | -24.14M | -21.88M | 0.52M | -32.29M | -33.40M | -23.67M | -6.15M | -43.84M | -49.94M | -33.35M | 9.00M | -23.57M | -14.35M | |||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -30.21M | -1.85M | -28.39M | -26.69M | -25.83M | -2.27M | -30.21M | -24.14M | -21.88M | 0.52M | -32.29M | -33.40M | -23.67M | -6.15M | -43.84M | -49.94M | -33.35M | 9.00M | -23.57M | -14.35M | |||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -30.21M | -1.85M | -28.39M | -26.69M | -25.83M | -2.27M | -30.21M | -24.14M | -21.88M | 0.52M | -32.29M | -33.40M | -23.67M | -6.15M | -43.84M | -49.94M | -33.35M | 9.00M | -23.57M | -14.35M | |||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -1.35 | -0.08 | -1.25 | -1.18 | -1.13 | -0.10 | -1.30 | -1.03 | -0.68 | 0.02 | -0.97 | -0.91 | -0.55 | -0.14 | -0.92 | -1.05 | -0.69 | 0.19 | -0.47 | -0.28 | |||||||||||||||||||
| Shares Outstanding | 22.38M | 22.35M | 22.63M | 22.70M | 22.80M | 22.81M | 23.28M | 23.46M | 32.30M | 28.83M | 33.38M | 36.82M | 43.10M | 42.88M | 47.42M | 47.74M | 48.06M | 48.12M | 50.18M | 50.38M | |||||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 22.40M | 22.50M | 22.70M | 22.73M | 23.01M | 23.13M | 23.44M | 23.50M | 30.90M | 32.50M | 36.13M | 41.20M | 42.19M | 42.23M | 46.10M | 46.20M | 46.80M | 48.40M | 48.71M | 48.90M | |||||||||||||||||||
| EBITDA | -23.44M | -19.91M | -21.96M | -18.71M | -18.09M | -20.28M | -22.05M | -15.38M | -13.50M | -14.61M | -25.74M | -25.84M | -17.55M | -27.66M | -36.91M | -41.45M | -27.39M | -19.11M | -20.26M | 0.11M | |||||||||||||||||||
| Tax Rate | 93.23% | -1.16% | -0.12% | -2.82% | 91.96% | -0.07% | -0.22% | 0.04% | 102.34% | -0.17% | -0.11% | -0.39% | 82.36% | -0.90% | -2.07% | 3.06% | 133.79% | 16.83% | -64.54% |